EGR1 regulates PDE12 mediated mitochondrial dysfunction to induce oral mucosal epithelial barrier damage in oral...

The treatment of oral submucosal fibrosis (OSF) is challenging owing to the complex pathogenesis. It is characterized by excessive collagen deposition in the subepithelium along with epithelial damage. Betel nut chewing is considered a major cause of OSF. We previously found that phosphodiesterase 12 (PDE12) was involved in the oral mucosal epithelial barrier damage, promoting the occurrence of OSF. Early growth response 1 (EGR1), a well-characterized transcription factor, has been implicated in the development of fibrotic diseases, including oral fibrosis. This study aimed to explore the effects and underlying mechanisms of PDE12 overexpression on oral epithelial cells in OSF. Overexpression of PDE12 was employed to verify its critical role in mitochondrial dysfunction and oral mucosal epithelial barrier disruption in HOKs. Subsequently, electrophoretic mobility shift assay and chromatin immunoprecipitation analysis were performed to demonstrate that EGR1 interacted with the promoter of the PDE12 gene, thereby upregulating its expression in HOKs. By combining EGR1 silencing and PDE12 overexpressing strategies, our study confirmed that PDE12-induced impairment of mitochondrial function and oral mucosal epithelial barrier was dependent on EGR1. These findings suggest that regulating the expression of PDE12 through EGR1 could alleviate arecoline-induced epithelial injury, thereby inhibiting the development of OSF and offering a potential therapeutic strategy to combat OSF.